Harnessing stem cells and biomaterials to promote neural repair

被引:32
作者
Bruggeman, K. F. [2 ]
Moriarty, N. [3 ,4 ]
Dowd, E. [3 ,4 ]
Nisbet, D. R. [2 ]
Parish, C. L. [1 ]
机构
[1] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia
[2] Australian Natl Univ, Res Sch Engn, Lab Adv Biomat, Canberra, ACT, Australia
[3] Natl Univ Ireland Galway, Pharmacol & Therapeut, Galway, Ireland
[4] Natl Univ Ireland Galway, Galway Neurosci Ctr, Galway, Ireland
关键词
GROWTH-FACTOR DELIVERY; DOPAMINE NEURONS; PARKINSONS-DISEASE; FUNCTIONAL RECOVERY; HUMAN ES; NANOFIBROUS SCAFFOLDS; NEURITE INFILTRATION; EXTRACELLULAR-MATRIX; CEREBRAL-ISCHEMIA; AXON REGENERATION;
D O I
10.1111/bph.14545
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
With the limited capacity for self-repair in the adult CNS, efforts to stimulate quiescent stem cell populations within discrete brain regions, as well as harness the potential of stem cell transplants, offer significant hope for neural repair. These new cells are capable of providing trophic cues to support residual host populations and/or replace those cells lost to the primary insult. However, issues with low-level adult neurogenesis, cell survival, directed differentiation and inadequate reinnervation of host tissue have impeded the full potential of these therapeutic approaches and their clinical advancement. Biomaterials offer novel approaches to stimulate endogenous neurogenesis, as well as for the delivery and support of neural progenitor transplants, providing a tissue-appropriate physical and trophic milieu for the newly integrating cells. In this review, we will discuss the various approaches by which bioengineered scaffolds may improve stem cell-based therapies for repair of the CNS.
引用
收藏
页码:355 / 368
页数:14
相关论文
共 112 条
[1]   Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons [J].
Adil, Maroof M. ;
Vazin, Tandis ;
Ananthanarayanan, Badriprasad ;
Rodrigues, Goncalo M. C. ;
Rao, Antara T. ;
Kulkarni, Rishikesh U. ;
Miller, Evan W. ;
Kumar, Sanjay ;
Schaffer, David V. .
BIOMATERIALS, 2017, 136 :1-11
[2]  
Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
[3]  
Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI [10.1111/bph.13877, 10.1111/bph.13882]
[4]   ARE NEW NEURONS FORMED IN BRAINS OF ADULT MAMMALS [J].
ALTMAN, J .
SCIENCE, 1962, 135 (3509) :1127-&
[5]   Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges [J].
Amer, Mahetab H. ;
Rose, Felicity R. A. J. ;
Shakesheff, Kevin M. ;
Modo, Michel ;
White, Lisa J. .
NPJ REGENERATIVE MEDICINE, 2017, 2
[6]  
[Anonymous], STEM CELLS CANC STEM
[7]   Neuronal replacement from endogenous precursors in the adult brain after stroke [J].
Arvidsson, A ;
Collin, T ;
Kirik, D ;
Kokaia, Z ;
Lindvall, O .
NATURE MEDICINE, 2002, 8 (09) :963-970
[8]   Neural stem/precursor cells for the treatment of ischemic stroke [J].
Bacigaluppi, Marco ;
Pluchino, Stefano ;
Martino, Gianvito ;
Kilic, Ertugrul ;
Hermann, Dirk M. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 265 (1-2) :73-77
[9]   Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era [J].
Barker, Roger A. ;
Parmar, Malin ;
Studer, Lorenz ;
Takahashi, Jun .
CELL STEM CELL, 2017, 21 (05) :569-573
[10]   Apoptosis in neuronal development and transplantation: Role of caspases and trophic factors [J].
Boonman, Z ;
Isacson, O .
EXPERIMENTAL NEUROLOGY, 1999, 156 (01) :1-15